Fatal cytokine release syndrome by an aberrant FLIP/STAT3 axis

Area of Science:

• Immunology
• Pathophysiology
• Molecular Biology

Background:

• Inflammatory responses are crucial for pathogen detection but can become dysregulated.
• Cytokine release syndrome (CRS) is a life-threatening inflammatory pathology.
• The pathophysiology of CRS, particularly in COVID-19, remains unclear.

Purpose of the Study:

• To investigate the role of FLIP protein in CRS.
• To elucidate the molecular mechanisms underlying CRS.
• To identify potential therapeutic targets for CRS.

Main Methods:

• Examined FLIP protein expression in myeloid cells from COVID-19 lungs.
• Utilized a mouse model with constitutive expression of a viral FLIP homolog.
• Assessed the impact of STAT3-targeting interventions in the mouse model.

Main Results:

• FLIP was highly expressed in myeloid cells of COVID-19 lungs and fueled a STAT3-dependent inflammatory program.
• Constitutive FLIP expression in mice induced a fatal inflammatory syndrome mimicking human CRS.
• STAT3-targeting approaches ameliorated inflammation, immune disorders, and organ failures in mice.

Conclusions:

• FLIP plays a critical role in CRS pathogenesis by activating STAT3.
• Targeting the STAT3 pathway presents a promising therapeutic strategy for suppressing lethal CRS.
• Understanding FLIP-STAT3 interactions is key to managing severe inflammatory conditions.